MarketCap
Facebook
X
TelegramAnnual report 2024
added 12-27-2025
Check-Cap Ltd. ROCE Ratio 2011-2025 | CHEK
Annual ROCE Ratio Check-Cap Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1809.55 | - | -47.66 | -33.56 | -83.64 | -212.3 | -83.72 | -157.65 | -82.92 | -94.24 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1809.55 | -212.3 | 112.65 |
Quarterly ROCE Ratio Check-Cap Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -13.41 | -26.82 | -26.82 | -13.41 | -32.68 | -38.55 | -38.55 | -19.27 | -44.7 | -50.85 | -50.85 | -25.43 | -39.58 | -28.31 | -28.31 | -14.15 | -48.38 | -68.45 | -68.45 | -34.22 | -55.51 | -42.57 | -42.57 | -21.28 | -35.8 | -29.03 | -29.03 | -14.52 | -14.52 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -13.41 | -68.45 | -34.34 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
-17.75 | $ 19.05 | 0.34 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 21.0 | 1.82 % | $ 226 M |  China |
 |
Co-Diagnostics
CODX
|
-47.68 | $ 0.18 | -1.55 % | $ 5.28 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 39.22 | -0.24 % | $ 1.09 B | USA |
 |
Danaher Corporation
DHR
|
9.82 | $ 229.96 | -0.31 % | $ 168 B | USA |
 |
DarioHealth Corp.
DRIO
|
-66.97 | $ 10.5 | -1.87 % | $ 298 M | Israel |
 |
BioNano Genomics
BNGO
|
-293.94 | $ 1.51 | 0.67 % | $ 1.92 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-36.48 | $ 101.9 | - | $ 18.9 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
28.89 | $ 66.82 | -0.37 % | $ 25.8 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 26.28 | -0.79 % | $ 795 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-77.82 | $ 18.79 | -1.49 % | $ 1.01 B | USA |
 |
Celcuity
CELC
|
-97.97 | $ 99.21 | -0.71 % | $ 3.91 B | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
-69.16 | $ 3.11 | -0.32 % | $ 99.2 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
36.29 | $ 226.18 | -0.65 % | $ 41 B | USA |
 |
Guardant Health
GH
|
317.65 | $ 102.07 | 1.46 % | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
-486.78 | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
-17.62 | $ 6.17 | - | $ 559 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-281.17 | $ 4.55 | -4.41 % | $ 2.44 M | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 7.05 | -0.07 % | $ 1.53 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 27.19 | -0.75 % | $ 20 B |  Niderland |
 |
Personalis
PSNL
|
-33.64 | $ 7.93 | -0.5 % | $ 470 M | USA |
 |
Quidel Corporation
QDEL
|
69.35 | $ 29.0 | -1.02 % | $ 1.22 B | USA |
 |
National Research Corporation
NRC
|
81.8 | $ 18.42 | -1.26 % | $ 452 M | USA |
 |
RadNet
RDNT
|
11.59 | $ 71.33 | -0.22 % | $ 5.21 B | USA |
 |
Illumina
ILMN
|
-35.1 | $ 131.5 | -0.94 % | $ 20.9 B | USA |
 |
Charles River Laboratories International
CRL
|
6.57 | $ 201.1 | -0.44 % | $ 10.3 B | USA |
 |
Soleno Therapeutics
SLNO
|
-76.57 | $ 45.22 | -2.32 % | $ 1.82 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.86 | $ 174.8 | -0.4 % | $ 19.4 B | USA |
|
Biodesix
BDSX
|
-41.6 | $ 6.61 | -1.64 % | $ 857 M | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
13.5 | $ 252.06 | -0.4 % | $ 21.1 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 182.26 | -0.4 % | $ 15 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
50.7 | $ 681.09 | -0.18 % | $ 56.2 B | USA |
 |
Lantheus Holdings
LNTH
|
42.0 | $ 66.97 | -0.28 % | $ 4.63 B | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 404.2 | -0.72 % | $ 29.8 B |  Schweiz |